• Biologics
    • Modalities
      • Mammalian
      • Microbial
      • ADCs / Bioconjugates
      • mRNA / LNP
      • Drug Product
    • Technologies & Products
      • Expression Technologies
      • Discovery Products
      • Bioprocessing Products
    • Discovery and Preclinical
      • Early De-risking & Optimization
      • Cell Line & Strain Development
      • Process Development & Optimization
      • Analytical Development
      • Formulation Development
      • Non-GMP Manufacture
    • Clinical and Commercial
      • Process Development & Optimization
      • Formulation Optimization
      • cGMP Drug Substance Manufacture
      • cGMP Drug Product Manufacture
    Technical Support
    Regulatory Support
    View all locations
    View all Biologics offerings
    Woman and microscope

    Knowledge Center

    View all the latest resources available on site


    Visit our Knowledge Center

  • Small Molecules
    • Services
      • Drug Substance (API)
      • Particle Engineering
      • Drug Product
    • Technologies
      • Highly Potent API (HPAPI)
      • ADCs
      • Spray Dried Dispersions
      • Micronization & Jet Milling
      • Inhaled Delivery (DPI)
    • Solutions
      • Early Phase API
      • Commercial Production API
      • Bioavailability Enhancement
      • Integrated Offerings
    • Knowledge Center
      • Webinars
      • Presentations
      • Publications
      • Meet the Experts
      • View all
    View all Small Molecules offerings
    View all locations
    Clinical drug development & preformulation

    Knowledge Center

    View all the latest resources


    Visit our Knowledge Center

  • Cell & Gene
    • Services
      • Process Development
      • cGMP Manufacturing
      • Regulatory Consulting
      • Bioassay Services
      • Tissue Acquisition
    • Modalities
      • Autologous
      • Allogeneic
      • Viral Vectors
      • iPSCs
      • Exosomes
    • Technologies
      • MODA® Platform
      • Cocoon® Platform
      • Nucleofector® Technology
      • TheraPEAK® Media
      • Endotoxin and Pyrogen Testing
    • Knowledge Center
      • Webinars
      • Articles
      • Whitepapers & Publications
      • eBooks
      • Presentations
      • View all
    View all Cell & Gene offerings
    View all Bioscience Products
    View all locations
  • Capsules & Health Ingredients
    • Health Ingredients
    • Nutraceutical capsules
    • Pharmaceutical capsules
    • Capsule filling equipment
  • Contact
  • Trending Topics
    New Cambridge, USA Lab Expands Our Early De-risking Capacity
    Upcoming Conference PEGS Boston 2023, USA
    New Whitepaper: Optimization of mRNA Manufacturing
    Shaped Around You - Committed to your molecule’s IND
    New Whitepaper: Late-Phase Drug Product Development and Launch
Trending Topics
New Cambridge, USA Lab Expands Our Early De-risking Capacity
Upcoming Conference PEGS Boston 2023, USA
New Whitepaper: Optimization of mRNA Manufacturing
Shaped Around You - Committed to your molecule’s IND
New Whitepaper: Late-Phase Drug Product Development and Launch
Biologics
Biologics
Modalities
  • Mammalian
  • Microbial
  • ADCs / Bioconjugates
  • mRNA / LNP
  • Drug Product
Technologies & Products
  • Expression Technologies
  • Discovery Products
  • Bioprocessing Products
Discovery and Preclinical
  • Early De-risking & Optimization
  • Cell Line & Strain Development
  • Process Development & Optimization
  • Analytical Development
  • Formulation Development
  • Non-GMP Manufacture
Clinical and Commercial
  • Process Development & Optimization
  • Formulation Optimization
  • cGMP Drug Substance Manufacture
  • cGMP Drug Product Manufacture
Back
Small Molecules
Small Molecules
Services
  • Drug Substance (API)
  • Particle Engineering
  • Drug Product
Technologies
  • Highly Potent API (HPAPI)
  • ADCs
  • Spray Dried Dispersions
  • Micronization & Jet Milling
  • Inhaled Delivery (DPI)
Solutions
  • Early Phase API
  • Commercial Production API
  • Bioavailability Enhancement
  • Integrated Offerings
Knowledge Center
  • Webinars
  • Presentations
  • Publications
  • Meet the Experts
  • View all
Back
Cell & Gene
Cell & Gene
Services
  • Process Development
  • cGMP Manufacturing
  • Regulatory Consulting
  • Bioassay Services
  • Tissue Acquisition
Modalities
  • Autologous
  • Allogeneic
  • Viral Vectors
  • iPSCs
  • Exosomes
Technologies
  • MODA® Platform
  • Cocoon® Platform
  • Nucleofector® Technology
  • TheraPEAK® Media
  • Endotoxin and Pyrogen Testing
Knowledge Center
  • Webinars
  • Articles
  • Whitepapers & Publications
  • eBooks
  • Presentations
  • View all
Back
Capsules & Health Ingredients
Capsules & Health Ingredients
Health Ingredients
Nutraceutical capsules
Pharmaceutical capsules
Capsule filling equipment
Back
Contact
Back
  • Home
  • Biologics
  • Mammalian Biopharmaceutical Services
  • Tailored License Application Program

Our Tailored License Application Program

Ensure that your therapies for serious conditions are available to patients as soon as possible. Achieve License Application success with Lonza’s unparalleled track-record and experience using a structured CMC approach, matching your product, process, timeline and risk tolerance.
Prepare your Market License Application
45+ License Applications
100% Success Rate of Drug Substance License Application Submissions
60+ Regulatory Experts Providing Global Regulatory Expertise and Support
A structured License Application approach tailored to support your product, process, timeline and risk tolerance.

A License Application requires a detailed CMC package of information to support submission. The Drug Substance and Drug Product packages are tailored according to:

  • Key milestones
    • Pivotal study readout date
    • Clinical urgency and expedited status
    • Planned submission date
  • Material requirements
    • Clinical re-supply
    • Initial launch supply
  • Commercial supply strategy
    • Initial supply site
    • Subsequent supply site (if required)
  • Customer’s tolerance to risk

A step-wise approach is applied to ensure collaboration and Customer alignment throughout the CMC journey.

The CMC data package encompasses analytical development and method validation, small scale process characterization studies, GMP validation batches (PPQ batches), process validation studies and product-related analytical studies.

A combination of small scale and large scale experimentation is used to establish scientific evidence that a process is capable of consistently delivering quality products.


The key to success is experience, track record and expertise.
  • 100% License Application success rate in all our mammalian history
  • Regulatory support from 60+ team members aligned with manufacturing sites around the globe
  • Global regulatory expertise & support throughout the development life from early phase to post-approval/ lifecycle management
  • Draft of detailed CMC information sections with Customer review and eCTD ready
  • Timely post-submission responses to questions from regulatory authorities
  • Supported 45 approval inspections across the globe

Our regulatory experts can support you through the journey with:

  • Experience
  • Track record
  • Knowledge of the ‘what’ and the ‘how’

Related Offerings

Biologics Analytical Development
Benefit from access to our preclinical analytical services, supporting all stages of product and...
Learn More
Biologics Process Development
We can help scale up and optimize your preclinical process development across mammalian, microbial...
Learn More
Mammalian Drug Substance Manufacturing
Our global biopharmaceutical mammalian manufacturing network offers a range of cGMP production...
Learn More
Parenteral Drug Product Services
Phase-appropriate approach to parenteral drug product development and manufacturing; ensuring your...
Learn More
Parenteral Drug Product Formulation Development
We offer formulation development for all biologics modalities and dosage forms. Learn more.
Learn More
Biologics

Related Insights

Knowledge Center
People cycling at Reforma street in Mexico city.
Webinar (on-demand)
Biologics License Application Success Using A Structured Approach
This webinar will focus on the critical chemistry, manufacturing and controls (CMC) elements of a...
lab techs
Article
A Stepwise Approach To CMC Planning For A Biologics License Application
The complexity and diversity of today’s pipelines are creating new challenges throughout every stage...
Knowledge Center

Latest news

View all articles
29 Mar 2023
News Release
Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH)
View Article
29 Mar 2023
News Release
Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH)
View Article
29 Mar 2023
News Release
Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH)
View Article
16 Feb 2023
News Release
Lonza Completes Expansion of Conjugation Facility in Visp (CH)
View Article
16 Feb 2023
News Release
Lonza Completes Expansion of Conjugation Facility in Visp (CH)
View Article
16 Feb 2023
News Release
Lonza Completes Expansion of Conjugation Facility in Visp (CH)
View Article
13 Feb 2023
Media Advisory
Lonza to Expand Early Development Services Offering into North America
View Article
13 Feb 2023
Media Advisory
Lonza to Expand Early Development Services Offering into North America
View Article
View all articles
Ways to Contact
  • Contact Us
  • Regulatory Support
  • Locations
  • Partnering with Us
Resources
  • Knowledge Center
  • Meet the Experts
  • Upcoming Events
Terms & Conditions
  • Terms and Conditions
  • Legal Disclaimer
  • Privacy Policy
  • California CCPA Notice
  • Transparency in Coverage
Lonza.com
  • Company Overview
  • News & Media
  • Investor Relations
  • Sustainability
  • Careers
  • Sitemap
© 2023 Lonza. All rights reserved.